Publications searcher

The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points.

[Acute stent thrombosis and reverse transient left ventricular dilatation after performing a single-photon emission computed tomography myocardial perfusion].

PMID: 25129322
Journal: Revista Espanola de Medicina Nuclear e Imagen Molecular
Year: 2015
Reference: Rev Esp Med Nucl Imagen Mol. 2015 Mar-Apr;34(2):107-10. doi: 10.1016/j.remn.2014.07.005. Epub 2014 Aug 14.
Impact factor: 1.054
Publication type: Paper in national publication
Authors: Miranda, B, Pizzi, M N, Aguade-Bruix, S, Domingo, E, Candell-Riera, J et al.
DOI: 10.1016/j.remn.2014.07.005

[Acute stent thrombosis and reverse transient left ventricular dilatation after performing a single-photon emission computed tomography myocardial perfusion].

PMID: 25129322
Journal: REV ESP MED NUCL IMA
Year: 2015
Reference: Rev Esp Med Nucl Imagen Mol. 2015 Mar-Apr;34(2):107-10. doi: 10.1016/j.remn.2014.07.005. Epub 2014 Aug 14.
Impact factor:
Publication type: Paper in national publication
Authors: Aguade-Bruix, S; Candell-Riera, J; Domingo, E; Miranda, B; Pizzi, M N et al.
DOI: 10.1016/j.remn.2014.07.005

Acute Stroke or Transient Ischemic Attack Treated with Aspirin or Ticagrelor and Patient Outcomes (SOCRATES) trial: rationale and design.

PMID: 26311628
Journal: International Journal of Stroke
Year: 2015
Reference: Int J Stroke. 2015 Dec;10(8):1304-8. doi: 10.1111/ijs.12610. Epub 2015 Aug 26.
Impact factor: 3.833
Publication type: Paper in international publication
Authors: Easton, J Donald, Held, Peter, Jonasson, Jenny, Minematsu, Kazuo, Molina, Carlos A, Wong, Lawrence K S, Denison, Hans, Albers, Gregory W, Johnston, S Claiborne, Amarenco, Pierre et al.
DOI: 10.1111/ijs.12610

Acute Stroke or Transient Ischemic Attack Treated with Aspirin or Ticagrelor and Patient Outcomes (SOCRATES) trial: rationale and design.

PMID: 26311628
Journal: INT J STROKE
Year: 2015
Reference: Int J Stroke. 2015 Dec;10(8):1304-8. doi: 10.1111/ijs.12610. Epub 2015 Aug 26.
Impact factor:
Publication type: Paper in international publication
Authors: Albers, Gregory W; Amarenco, Pierre; Denison, Hans; Easton, J Donald; Held, Peter; Johnston, S Claiborne; Jonasson, Jenny; Minematsu, Kazuo; Molina, Carlos A; Wong, Lawrence K S et al.
DOI: 10.1111/ijs.12610

Acute type B aortic dissection complicated by visceral ischemia.

PMID: 25500101
Journal: JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
Year: 2015
Reference: J Thorac Cardiovasc Surg. 2015 Apr;149(4):1081-6.e1. doi: 10.1016/j.jtcvs.2014.11.012. Epub 2014 Nov 12.
Impact factor: 3.991
Publication type: Paper in international publication
Authors: Fattori, Rossella, Di Eusanio, Marco, Evangelista, Arturo, Nienaber, Christoph A, Isselbacher, Eric M, Eagle, Kim A, Trimarchi, Santi, Sechtem, Udo, Braverman, Alan C, Montgomery, Daniel G et al.
DOI: 10.1016/j.jtcvs.2014.11.012

Acute type B aortic dissection complicated by visceral ischemia.

PMID: 25500101
Journal: J THORAC CARDIOV SUR
Year: 2015
Reference: J Thorac Cardiovasc Surg. 2015 Apr;149(4):1081-6.e1. doi: 10.1016/j.jtcvs.2014.11.012. Epub 2014 Nov 12.
Impact factor:
Publication type: Paper in international publication
Authors: Braverman, Alan C; Di Eusanio, Marco; Eagle, Kim A; Evangelista, Arturo; Fattori, Rossella; Gleason, Thomas G; Isselbacher, Eric M; Jonker, Frederik H W; Montgomery, Daniel G; Nienaber, Christoph A et al.
DOI: 10.1016/j.jtcvs.2014.11.012

Additional mechanisms conferring genetic susceptibility to Alzheimer's disease.

PMID: 25914626
Journal: Frontiers in Cellular Neuroscience
Year: 2015
Reference: Front Cell Neurosci. 2015 Apr 9;9:138. doi: 10.3389/fncel.2015.00138. eCollection 2015.
Impact factor: 4.609
Publication type: Review in national publication
Authors: Calero, Miguel, Gomez-Ramos, Alberto, Calero, Olga, Soriano, Eduardo, Avila, Jesus, Medina, Miguel et al.
DOI: 10.3389/fncel.2015.00138

Additional mechanisms conferring genetic susceptibility to Alzheimer's disease.

PMID: 25914626
Journal: FRONT CELL NEUROSCI
Year: 2015
Reference: Front Cell Neurosci. 2015 Apr 9;9:138. doi: 10.3389/fncel.2015.00138. eCollection 2015.
Impact factor:
Publication type: Review in national publication
Authors: Avila, Jesus; Calero, Miguel; Calero, Olga; Gomez-Ramos, Alberto; Medina, Miguel; Soriano, Eduardo et al.
DOI: 10.3389/fncel.2015.00138

Adherence to prophylaxis and quality of life in children and adolescents with severe haemophilia A.

PMID: 25649244
Journal: HAEMOPHILIA
Year: 2015
Reference: Haemophilia. 2015 Jul;21(4):458-64. doi: 10.1111/hae.12618. Epub 2015 Feb 4.
Impact factor: 2.603
Publication type: Paper in international publication
Authors: Garcia-Dasi, M, Aznar, J A, Jimenez-Yuste, V, Altisent, C, Bonanad, S, Mingot, E, Lucia, F, Gimenez, F, Lopez, M Fernanda, Marco, P et al.
DOI: 10.1111/hae.12618

Adherence to prophylaxis and quality of life in children and adolescents with severe haemophilia A.

PMID: 25649244
Journal: HAEMOPHILIA
Year: 2015
Reference: Haemophilia. 2015 Jul;21(4):458-64. doi: 10.1111/hae.12618. Epub 2015 Feb 4.
Impact factor:
Publication type: Paper in international publication
Authors: Altisent, C; Aznar, J A; Bonanad, S; Fernandez, M A; Galmes, B; Garcia-Dasi, M; Garcia-Talavera, J A; Gimenez, F; Herrero, S; Jimenez-Yuste, V et al.
DOI: 10.1111/hae.12618

Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study.

PMID: 26527776
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2015
Reference: J Clin Oncol. 2015 Dec 10;33(35):4176-87. doi: 10.1200/JCO.2015.63.4238. Epub 2015 Nov 2.
Impact factor: 18.428
Publication type: Paper in international publication
Authors: Duval, Alex, de Gramont, Armand, Vernerey, Dewi, Chibaudel, Benoist, Bonnetain, Franck, Tijeras-Raballand, Annemilai, Scriva, Aurelie, Hickish, Tamas, Tabernero, Josep, Van Laethem, Jean Luc et al.
DOI: 10.1200/JCO.2015.63.4238

Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study.

PMID: 26527776
Journal: J CLIN ONCOL
Year: 2015
Reference: J Clin Oncol. 2015 Dec 10;33(35):4176-87. doi: 10.1200/JCO.2015.63.4238. Epub 2015 Nov 2.
Impact factor:
Publication type: Paper in international publication
Authors: Andre, Thierry; Banzi, Maria; Bonnetain, Franck; Carlsson, Goran U; Chibaudel, Benoist; Colote, Soudhir; de Gramont, Aimery; de Gramont, Armand; Demetter, Pieter; Duval, Alex et al.
DOI: 10.1200/JCO.2015.63.4238

Adjuvant Ovarian Suppression in Premenopausal Breast Cancer.

PMID: 25495490
Journal: NEW ENGLAND JOURNAL OF MEDICINE
Year: 2015
Reference: N Engl J Med. 2015 Jan 29;372(5):436-46. doi: 10.1056/NEJMoa1412379. Epub 2014 Dec 11.
Impact factor: 55.873
Publication type: Paper in international publication
Authors: Price, Karen N, Colleoni, Marco, Viale, Giuseppe, Coates, Alan S, Goldhirsch, Aron, Gelber, Richard D, Giobbie-Hurder, Anita, Ruepp, Barbara, Rabaglio-Poretti, Manuela, Francis, Prudence A et al.
DOI: 10.1056/NEJMoa1412379

Adjuvant Ovarian Suppression in Premenopausal Breast Cancer.

PMID: 25495490
Journal: NEW ENGL J MED
Year: 2015
Reference: N Engl J Med. 2015 Jan 29;372(5):436-46. doi: 10.1056/NEJMoa1412379. Epub 2014 Dec 11.
Impact factor:
Publication type: Paper in international publication
Authors: Bellet, Meritxell; Bonnefoi, Herve R; Buchholz, Stefan; Burstein, Harold J; Ciruelos, Eva; Climent, Miguel A; Coates, Alan S; Coleman, Robert; Colleoni, Marco; Davidson, Nancy E et al.
DOI: 10.1056/NEJMoa1412379

Adult ADHD Screening in Alcohol-Dependent Patients Using the Wender-Utah Rating Scale and the Adult ADHD Self-Report Scale.

PMID: 24743975
Journal: Journal of Attention Disorders
Year: 2015
Reference: J Atten Disord. 2015 Apr;19(4):328-34. doi: 10.1177/1087054714529819. Epub 2014 Apr 17.
Impact factor: 3.779
Publication type: Paper in international publication
Authors: Roncero, Carlos, Rodriguez-Cintas, Laia, Ortega, Lluisa, Lligona, Anna, Fuentes, Sonia, Perez-Pazos, Jesus, Martinez-Luna, Nieves, Casas, Miguel, Daigre, Constanza et al.
DOI: 10.1177/1087054714529819

Adult ADHD Screening in Alcohol-Dependent Patients Using the Wender-Utah Rating Scale and the Adult ADHD Self-Report Scale.

PMID: 24743975
Journal: J ATTEN DISORD
Year: 2015
Reference: J Atten Disord. 2015 Apr;19(4):328-34. doi: 10.1177/1087054714529819. Epub 2014 Apr 17.
Impact factor:
Publication type: Paper in international publication
Authors: Casas, Miguel; Daigre, Constanza; Fuentes, Sonia; Lligona, Anna; Martinez-Luna, Nieves; Ortega, Lluisa; Perez-Pazos, Jesus; Rodriguez-Cintas, Laia; Roncero, Carlos et al.
DOI: 10.1177/1087054714529819

Advanced neuroprotection for brain ischemia: an alternative approach to minimize stroke damage.

PMID: 26138255
Journal: EXPERT OPINION ON INVESTIGATIONAL DRUGS
Year: 2015
Reference: Expert Opin Investig Drugs. 2015 Sep;24(9):1137-42. doi: 10.1517/13543784.2015.1065040. Epub 2015 Jul 3.
Impact factor: 5.528
Publication type: Paper in international publication
Authors: Ayuso, Maria Irene, Montaner, Joan et al.
DOI: 10.1517/13543784.2015.1065040

Advanced neuroprotection for brain ischemia: an alternative approach to minimize stroke damage.

PMID: 26138255
Journal: EXPERT OPIN INV DRUG
Year: 2015
Reference: Expert Opin Investig Drugs. 2015 Sep;24(9):1137-42. doi: 10.1517/13543784.2015.1065040. Epub 2015 Jul 3.
Impact factor:
Publication type: Paper in international publication
Authors: Ayuso, Maria Irene; Montaner, Joan et al.
DOI: 10.1517/13543784.2015.1065040

Advances in the management of multiple sclerosis symptoms: pathophysiology and assessment of spasticity in multiple sclerosis.

PMID: 26611266
Journal: Neurodegenerative disease management
Year: 2015
Reference: Neurodegener Dis Manag. 2015;5(6 Suppl):15-7. doi: 10.2217/nmt.15.56.
Impact factor: 0
Publication type: Paper in international publication
Authors: Tintore, Mar et al.
DOI: 10.2217/nmt.15.56

Advances in the management of multiple sclerosis symptoms: pathophysiology and assessment of spasticity in multiple sclerosis.

PMID: 26611266
Journal: Neurodegenerative disease management
Year: 2015
Reference: Neurodegener Dis Manag. 2015;5(6 Suppl):15-7. doi: 10.2217/nmt.15.56.
Impact factor:
Publication type: Paper in international publication
Authors: Tintore, Mar et al.
DOI: 10.2217/nmt.15.56

Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial.

PMID: 26156651
Journal: LANCET ONCOLOGY
Year: 2015
Reference: Lancet Oncol. 2015 Aug;16(8):897-907. doi: 10.1016/S1470-2045(15)00006-6. Epub 2015 Jul 5.
Impact factor: 24.69
Publication type: Paper in international publication
Authors: Syrigos, Konstantinos, Soria, Jean-Charles, Felip, Enriqueta, Cobo, Manuel, Lu, Shun, Georgoulias, Vassilis, Li, Wei, Isla, Dolores, Guclu, Salih Z, Morabito, Alessandro et al.
DOI: 10.1016/S1470-2045(15)00006-6

Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial.

PMID: 26156651
Journal: LANCET ONCOL
Year: 2015
Reference: Lancet Oncol. 2015 Aug;16(8):897-907. doi: 10.1016/S1470-2045(15)00006-6. Epub 2015 Jul 5.
Impact factor:
Publication type: Paper in international publication
Authors: Ardizzoni, Andrea; Chand, Vikram K; Cobo, Manuel; Felip, Enriqueta; Gadgeel, Shirish M; Georgoulias, Vassilis; Goker, Erdem; Goss, Glenwood D; Guclu, Salih Z; Isla, Dolores et al.
DOI: 10.1016/S1470-2045(15)00006-6

Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial.

PMID: 25892145
Journal: LANCET ONCOLOGY
Year: 2015
Reference: Lancet Oncol. 2015 May;16(5):583-94. doi: 10.1016/S1470-2045(15)70124-5. Epub 2015 Apr 16.
Impact factor: 24.69
Publication type: Paper in international publication
Authors: Rottey, Sylvie, Caponigro, Francesco, Castro, Gilberto Jr, Clement, Paul, del Campo, Joseph M, Cupissol, Didier, Degardin, Marian, Dietz, Andreas, Dreosti, Lydia Mary, Even, Caroline et al.
DOI: 10.1016/S1470-2045(15)70124-5

Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial.

PMID: 25892145
Journal: LANCET ONCOL
Year: 2015
Reference: Lancet Oncol. 2015 May;16(5):583-94. doi: 10.1016/S1470-2045(15)70124-5. Epub 2015 Apr 16.
Impact factor:
Publication type: Paper in international publication
Authors: Alfonsi, Marc; Avitia, Miguel Angel Alvarez; Axelrod, Rita; Bauernhofer, Thomas; Benasso, Marco; Billan, Salam; Brummendorf, Tim Henrik; Burtness, Barbara; Caponigro, Francesco; Caponigro, Francesco et al.
DOI: 10.1016/S1470-2045(15)70124-5

Publications

Publications searcher

[Acute stent thrombosis and reverse transient left ventricular dilatation after performing a single-photon emission computed tomography myocardial perfusion].

[Acute stent thrombosis and reverse transient left ventricular dilatation after performing a single-photon emission computed tomography myocardial perfusion].

Acute Stroke or Transient Ischemic Attack Treated with Aspirin or Ticagrelor and Patient Outcomes (SOCRATES) trial: rationale and design.

Acute Stroke or Transient Ischemic Attack Treated with Aspirin or Ticagrelor and Patient Outcomes (SOCRATES) trial: rationale and design.

Acute type B aortic dissection complicated by visceral ischemia.

Acute type B aortic dissection complicated by visceral ischemia.

Additional mechanisms conferring genetic susceptibility to Alzheimer's disease.

Additional mechanisms conferring genetic susceptibility to Alzheimer's disease.

Adherence to prophylaxis and quality of life in children and adolescents with severe haemophilia A.

Adherence to prophylaxis and quality of life in children and adolescents with severe haemophilia A.

Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study.

Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study.

Adjuvant Ovarian Suppression in Premenopausal Breast Cancer.

Adjuvant Ovarian Suppression in Premenopausal Breast Cancer.

Adult ADHD Screening in Alcohol-Dependent Patients Using the Wender-Utah Rating Scale and the Adult ADHD Self-Report Scale.

Adult ADHD Screening in Alcohol-Dependent Patients Using the Wender-Utah Rating Scale and the Adult ADHD Self-Report Scale.

Advanced neuroprotection for brain ischemia: an alternative approach to minimize stroke damage.

Advanced neuroprotection for brain ischemia: an alternative approach to minimize stroke damage.

Advances in the management of multiple sclerosis symptoms: pathophysiology and assessment of spasticity in multiple sclerosis.

Advances in the management of multiple sclerosis symptoms: pathophysiology and assessment of spasticity in multiple sclerosis.

Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial.

Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial.

Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial.

Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial.

Patronage:

Collaborating:

Accreditations: